Introducing AxiomVault: The World's First Blockchain-Native Molecular IP Marketplace
Today, we're launching AxiomVault — a platform that fundamentally changes how
#drugdiscovery #IP is created, verified, and transacted.
The Problem
Drug discovery is a $200B industry plagued by:
- Priority disputes — Who discovered it first?
- IP uncertainty — Is this scaffold already patented?
- Inefficient licensing — Months of negotiation for a single compound
Our Solution
AxiomVault combines three breakthrough technologies:
🧬 The Axiom Engine
Our AI predicts drug-like molecules with binding affinities, ADMET profiles, and synthesis routes. We're generating novel scaffolds faster than traditional discovery can validate them.
⛓️ The Provenance Chain
Every discovery is anchored to Bitcoin SV the instant it's created. This isn't just a timestamp — it's an immutable record that holds up in patent disputes, M&A due diligence, and regulatory filings.
📜 Smart Licensing
Four tiers. One click. From evaluation to full IP ownership, every transaction is recorded on-chain and legally binding.
For Pharma & Biotech
Stop reinventing the wheel.
Search our library of
#AI-predicted compounds. Find scaffolds in your therapeutic area. License what you need. Skip years of early-stage discovery.
- Preview leads before committing
- Lock exclusive rights in your field
- Acquire full IP with chain-of-title documentation
For Investors & Acquirers
Due diligence, solved.
Every compound on AxiomVault comes with:
- Verified discovery date
- Complete licensing history
- On-chain ownership record
No more "trust us" — verify it yourself at
axiomvault.io/verify
The future of molecular IP is transparent, verifiable, and on-chain.
Welcome to AxiomVault.
axiomvault.io/